Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




European Market for Hip, Knee Replacements

By HospiMedica staff writers
Posted on 13 Apr 2005
An aging population and technologic advances are projected to boost the hip and knee replacement market in Europe from an estimated U.S.$1.40 billion in 2004 to $1.83 billion in 2010, according to a new report from Frost & Sullivan (Palo Alto, CA, USA), international growth consultants.

Continued pressure to reduce the number of people waiting for joint replacement surgery has been paralleled by a shift in total knee and hip replacement procedures from major replacement centers to general acute hospitals. More...
This has reduced waiting times, augmented the number of procedures performed, and stimulated market growth.

Novel manufacturing techniques and new materials technology such as bone substitutes, bioabsorbable products, specialized alloys, and innovative joint-replacement product designs are all contributing to overall market value. Medical robotics, computer-assisted surgery, minimally invasive joint-replacement surgery, and bio-engineered technologies are projected to influence the development of innovative new products.

"The challenge to industry is to overcome some of the natural prejudices that the surgeons may have concerning robotics and computer assistance during surgery and ensure that implant technologies complement the use of computers during surgery,” cautioned Tanya Pullen, industry manager at Frost & Sullivan.

The competitive landscape has been shaped by a series of major acquisitions, mergers, and joint ventures. These changes have led to a streamlining of operational logistics, including the restructuring of manufacturing, sales, and marketing activities together with a rationalization of the product portfolio and product group responsibilities.

"In addition, the market has seen a slow but deliberate emphasis away from the use of local distributors, a consolidation of related orthopedic products and service activities, and a greater emphasis on supplying the market directly through subsidiaries,” noted Ms. Pullen.




Related Links:
Frost & Sullivan

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Digital Color Doppler Ultrasound System
MS22Plus
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.